Published online before print April 25, 2002, doi: 10.1161/01.ATV.0000020006.89055.11
© 2002 American Heart Association, Inc.
Vascular Biology |
Divergence of Angiogenic and Vascular Permeability Signaling by VEGF
Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability
From the Department of Cardiovascular Research, St. Elizabeth’s Medical Center, Boston, Mass.
Correspondence to Douglas W. Losordo, MD, Department of Cardiovascular Research, St. Elizabeth’s Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail douglas.losordo{at}tufts.edu
Abstract— Vascular endothelial growth factor (VEGF) promotes angiogenesis by a variety of mechanisms including stimulation of endothelial cell proliferation and migration and increasing vascular permeability. Although its mitogenic activity is mediated primarily by the ß2-isoforms of protein kinase C (PKC), little is known about the signaling pathways transducing its other physiological properties. Accordingly, we used a novel inhibitor molecule to examine the role of PKC isoforms 
and ß in mediating VEGF-induced angiogenesis and vascular permeability. Because conventional inhibitors of PKC, such as staurosporine or calphostin C, also inhibit a variety of other protein kinases, we used a novel compound to specifically inhibit PKC. A myristoylated peptide, which mimics the pseudosubstrate motif of PKC- and -ß subtypes, has been shown to be a highly selective and cell-permeable inhibitor of PKC. Blocking led, as expected, to abrogation of VEGF-induced endothelial cell proliferation in vitro. In vivo, VEGF-induced angiogenesis was impaired by myristoylated peptide. Surprisingly, selective inhibition of PKC induced vascular permeability in vivo via a NO-dependent mechanism. Moreover, PKC inhibition led to a 6.4-fold induction of NO synthase (NOS) activity in endothelial cells. Our findings demonstrate that activation of PKC is a major signaling pathway required for VEGF-induced proliferation and angiogenesis, whereas vascular permeability was enhanced by blocking PKC. Inhibition of calcium-dependent PKC by itself led to induction of NOS. Although NOS is a downstream target for VEGF-induced angiogenesis, its induction by PKC inhibition was not sufficient to promote neovascularization. These results reveal that angiogenesis and vascular permeability induced by VEGF are mediated by mechanisms which ultimately diverge.
Key Words: vascular endothelial growth factor • programmed cell death • angiogenesis • protein kinase C inhibitor • vascular permeability • nitric oxide
This article has been cited by other articles:
 |
|
 |
|
  D. Serban, J. Leng, and D. Cheresh H-Ras Regulates Angiogenesis and Vascular Permeability by Activation of Distinct Downstream Effectors Circ. Res., June 6, 2008; 102(11): 1350 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Komi, O. Ohno, Y. Suzuki, M. Shimamura, K. Shimokado, K. Umezawa, and S. Kojima Inhibition of Tumor Angiogenesis by Targeting Endothelial Surface ATP Synthase with Sangivamycin Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 867 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Y. Chen, G.-G. Feng, K. Nishiwaki, Y. Shimada, Y. Fujiwara, T. Komatsu, and N. Ishikawa Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transduction Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H959 - H967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jacobs, D. Zhu, S. Gruenloh, B. Lopez, and M. Medhora VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L369 - L377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lee, M. Aoki, T. Kondo, K. Kobayashi, K. Okumura, K. Komori, and T. Murohara Therapeutic Angiogenesis With Intramuscular Injection of Low-Dose Recombinant Granulocyte-Colony Stimulating Factor Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2535 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rudolfsson, P. Wikstrom, A. Jonsson, O. Collin, and A. Bergh Hormonal Regulation and Functional Role of Vascular Endothelial Growth Factor A in the Rat Testis Biol Reprod, February 1, 2004; 70(2): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Tickerhoof, P A. Farrell, and D. H. Korzick Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2694 - H2703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsuno, A. Ishisaki, K. Nakajima, K. Okada, S. Ueshima, O. Matsuo, and O. Kozawa Lack of {alpha}2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice Blood, November 15, 2003; 102(10): 3621 - 3628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamada, S. Kim, K. Egashira, M. Takeya, T. Ikeda, O. Mimura, and H. Iwao Molecular Mechanism and Role of Endothelial Monocyte Chemoattractant Protein-1 Induction by Vascular Endothelial Growth Factor Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 1996 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Eriksson, R. Cao, J. Roy, K. Tritsaris, C. Wahlestedt, S. Dissing, J. Thyberg, and Y. Cao Small GTP-Binding Protein Rac Is an Essential Mediator of Vascular Endothelial Growth Factor-Induced Endothelial Fenestrations and Vascular Permeability Circulation, March 25, 2003; 107(11): 1532 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Breslin, P. J. Pappas, J. J. Cerveira, R. W. Hobson II, and W. N. Duran VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H92 - H100. [Abstract] [Full Text] [PDF]
|
|